Sponsored by:
Presented by:

Multicolour Digital PCR for ctDNA detection in breast cancer
Tuesday, June 12, 2018

8AM PDT | 11AM EDT | 4PM BST | 5PM CEST

If you’ve already registered, please click here to log in to the webcast.

During the past years, interest in the use of circulating tumour DNA (ctDNA) as a non-invasive cancer biomarker has grown rapidly. Improvements in the genomic and molecular methods employed for ctDNA analysis are expanding the range of its potential applications, both in research settings and as a tool with clinical utility for cancer management. Several studies have demonstrated the attainability of ctDNA analysis to monitor response to treatment, assess the emergence of drug resistance and quantify minimal residual disease. In order to drive the implementation of ctDNA in personalized oncology and in cancer research several challenges remain to be circumvented.

During this webcast the speaker will address:

  • Technical challenges for clinical utility of liquid biopsy
  • ctDNA as a biomarker in breast cancer
  • dPCR for the detection of mutations on ctDNA
  • Understanding Multicolour dPCR
This webcast has been produced on behalf of the sponsor who retains sole responsibility for content. About this content
Presenter
Isaac Garcia-Murillas
Translational Senior Scientific Officer
The Institute of Cancer Research, London
View Biography
Presenter
Dr. Jayshan Carpen
Moderator
Nature Research
View Biography

Registration details:

Our registration process uses cookies, by submitting this registration form you agree to our cookie policy.

(*) denotes required form field(s)

Submit